RET, ROS1 and ALK fusions in lung cancer

Nature Medicine

Volumn 18, Issue 3, 2012, Pages 378-381

  Takeuchi, Kengo ^a   Soda, Manabu ^b   Togashi, Yuki ^a   Suzuki, Ritsuro ^c   Sakata, Seiji ^a   Hatano, Satoko ^a   Asaka, Reimi ^a   Hamanaka, Wakako ^a   Ninomiya, Hironori ^a   Uehara, Hirofumi ^d   Lim Choi, Young ^e   Satoh, Yukitoshi ^d,f   Okumura, Sakae ^d   Nakagawa, Ken ^d   Mano, Hiroyuki ^b,e   Ishikawa, Yuichi ^a  

^a CANCER INSTITUTE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; HYBRID PROTEIN; KINESIN; ONCOPROTEIN; PROTEIN RET; TYROSINE KINASE RECEPTOR;

ADULT; AGED; AGING; ARTICLE; C ROS ONCOGENE 1; CANCER STAGING; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULARLY TARGETED THERAPY; MULTIVARIATE ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; SCREENING; SEX DIFFERENCE;

3T3 CELLS; ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS, FUSION; PIPERIDINES; PROGNOSIS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; QUINAZOLINES; RECEPTOR PROTEIN-TYROSINE KINASES; SEX FACTORS;

EID: 84857985225     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2658     Document Type: Article

References (20)

1. Soda, M. et al. Nature 448, 561-566 (2007).
2. Takeuchi, K. et al. Clin. Cancer Res. 14, 6618-6624 (2008).
3. Takeuchi, K. et al. Clin. Cancer Res. 15, 3143-3149 (2009).
4. Rikova, K. et al. Cell 131, 1190-1203 (2007).
5. Takeuchi, K. et al. Haematologica 96, 464-467 (2011).
6. Takeuchi, K. et al. Clin. Cancer Res. 17, 3341-3348 (2011).
7. Sugawara, E. et al. Cancer published online, doi:10.1002/cncr.27391 (17 January 2012).
8. Choi, Y.L. et al. Cancer Res. 68, 4971-4976 (2008).
9. Inamura, K. et al. J. Thorac. Oncol. 3, 13-17 (2008).
10. Takeuchi, K. Pathol. and Clin. Med. 28, 139-144 (2010).
11. Jokoji, R. et al. J. Clin. Pathol. 63, 1066-1070 (2010).
12. Grieco, M. et al. Cell 60, 557-563 (1990).
13. Tognon, C. et al. Cancer Cell 2, 367-376 (2002).
14. Flanigan, J., Deshpande, H. & Gettinger, S. Biologics 4, 237-243 (2010).
15. Takahashi, M., Ritz, J. & Cooper, G.M. Cell 42, 581-588 (1985).
16. Ito, T. et al. Lancet 344, 259 (1994).
17. Hamatani, K. et al. Cancer Res. 68, 7176-7182 (2008).
18. Bounacer, A. et al. Oncogene 15, 1263-1273 (1997).
19. Kosaka, T. et al. Cancer Res. 64, 8919-8923 (2004).
20. Han, B. et al. Cancer Res. 68, 7629-7637 (2008).